---
title: Neuroimmune mechanisms of psychostimulant and opioid use disorders
authors: <table><tr><td>Traditional</td><td>Modern</td></tr><tr><td>MCP-1 (monocyte
  chemoattractant protein 1)</td><td>CCL2</td></tr><tr><td>MIP-1a (macrophage inflammatory
  protein-1 alpha)</td><td>CCL3</td></tr><tr><td>MIP-1β (macrophage inflammatory protein-1
  beta)</td><td>CCL4</td></tr><tr><td>RANTES (regulated on activation, normal Tcell
  expressed and secreted)</td><td>CCL5</td></tr><tr><td>MCP-2 (monocyte chemoattractant
  protein 2)</td><td>CCL8</td></tr><tr><td>ECP (eosinophil chemotactic protein)</td><td>CCL11</td></tr><tr><td>MCP-5
  (monocyte chemoattractant protein 5)</td><td>CCL12</td></tr><tr><td>TARC (thymus
  and activation-regulated chemokine)</td><td>CCL17</td></tr><tr><td>TECK (thymus-expressed
  chemokine)</td><td>CCL25</td></tr><tr><td>GRO/KC (growth-related oncogene/keratinocyte
  chemoattractant)</td><td>CXCL1</td></tr><tr><td>MIG (monokine induced by gamma interferon)</td><td>CXCL9</td></tr><tr><td>SDF-1
  (stromal cell-derived factor 1)</td><td>CXCL12</td></tr><tr><td>Fractalkine</td><td>CX3CL1</td></tr></table>
year: '2019'
type: literature-note
source: MinerU-extraction
extraction_path: extractions-mineru/2019 - Hofford - Neuroimmune mechanisms of psychostimulant
  and opioid use disorders
concepts: []
chapters:
- 1
tags:
- literature
- year-2019
- chapter-01
---

# Neuroimmune mechanisms of psychostimulant and opioid use disorders

## Metadata

- **Authors**: <table><tr><td>Traditional</td><td>Modern</td></tr><tr><td>MCP-1 (monocyte chemoattractant protein 1)</td><td>CCL2</td></tr><tr><td>MIP-1a (macrophage inflammatory protein-1 alpha)</td><td>CCL3</td></tr><tr><td>MIP-1β (macrophage inflammatory protein-1 beta)</td><td>CCL4</td></tr><tr><td>RANTES (regulated on activation, normal Tcell expressed and secreted)</td><td>CCL5</td></tr><tr><td>MCP-2 (monocyte chemoattractant protein 2)</td><td>CCL8</td></tr><tr><td>ECP (eosinophil chemotactic protein)</td><td>CCL11</td></tr><tr><td>MCP-5 (monocyte chemoattractant protein 5)</td><td>CCL12</td></tr><tr><td>TARC (thymus and activation-regulated chemokine)</td><td>CCL17</td></tr><tr><td>TECK (thymus-expressed chemokine)</td><td>CCL25</td></tr><tr><td>GRO/KC (growth-related oncogene/keratinocyte chemoattractant)</td><td>CXCL1</td></tr><tr><td>MIG (monokine induced by gamma interferon)</td><td>CXCL9</td></tr><tr><td>SDF-1 (stromal cell-derived factor 1)</td><td>CXCL12</td></tr><tr><td>Fractalkine</td><td>CX3CL1</td></tr></table>
- **Year**: 2019
- **Source**: MinerU extraction
- **Path**: `extractions-mineru/2019 - Hofford - Neuroimmune mechanisms of psychostimulant and opioid use disorders`

## Chapter Relevance

- [[Chapter 01]]: Introduction

## Full Text

See MinerU extraction: `extractions-mineru/2019 - Hofford - Neuroimmune mechanisms of psychostimulant and opioid use disorders/auto/*.md`

## Notes

*Add your synthesis notes here*

## Backlinks

*Papers citing this work will appear here via Obsidian backlinks*
